Chris Abell | |
---|---|
Born | Christopher Abell 11 November 1957 |
Died | 26 October 2020 | (aged 62)
Nationality | British |
Education | University of Cambridge (BA, MA, PhD) |
Known for | Astex[3] biosynthesis as targets for the rational design of antimicrobials; fragment-based approaches to enzyme inhibition; and biological nanotechnology |
Awards | Hickinbottom Award (1991) |
Scientific career | |
Fields | Biological chemistry |
Institutions | University of Cambridge Brown University |
Thesis | Polyketide biosynthesis (1982) |
Doctoral advisor | James Staunton |
Doctoral students | Shankar Balasubramanian[1] Alessio Ciulli[2] |
Website | www |
Christopher Abell (11 November 1957[4] – 26 October 2020[5]) was a British biological chemist who was a professor of biological chemistry at the Yusuf Hamied Department of Chemistry and Todd-Hamied Fellow of Christ's College, Cambridge.[6] On his 2016 election to the Royal Society, Abell's research was described as having "changed the face of drug discovery."[7]